Clinical Trials on Type 3 Choroidal Neovascularization in Korea, Democratic People's Republic of
Total 21 results
-
Kim's Eye HospitalCompletedAge-Related Macular Degeneration | Choroidal Neovascularization | Polypoidal Choroidal VasculopathyKorea, Republic of
-
Pusan National University HospitalNovartisCompletedExudative Age-related Macular DegenerationKorea, Republic of
-
Shahid Beheshti University of Medical SciencesCompletedChoroidal NeovascularizationIran, Islamic Republic of
-
Novartis PharmaceuticalsRecruitingMacular Polypoidal Choroidal Vasculopathy (PCV)Korea, Republic of
-
NovartisCompletedAge-Related Macular Degeneration | Choroidal NeovascularizationTaiwan, Korea, Republic of
-
Novartis PharmaceuticalsCompletedChoroidal Neovascularization (CNV)Korea, Republic of, Germany, Russian Federation, Turkey, Australia, Hungary, Switzerland, Italy, Lithuania, Denmark, Peru, Spain, Portugal, Canada, France, Latvia, Greece, Slovakia, Czech Republic, Poland, Singapore
-
Hoffmann-La RocheRecruitingChoroidal Neovascularization Secondary to Pathologic MyopiaKorea, Republic of, China, Australia, Singapore, Poland, France, Germany, Italy, Taiwan, Hong Kong
-
AllerganCompletedChoroidal Neovascularization | Age-Related MaculopathyFrance, Korea, Republic of, New Zealand, Italy, Israel, United States, Portugal, Australia, United Kingdom
-
BayerRegeneron PharmaceuticalsCompletedMyopia, PathologicalJapan, Taiwan, Hong Kong, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsCompletedVisual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)China, India, Thailand, Hong Kong, Korea, Republic of, Philippines
-
Novartis PharmaceuticalsCompletedAge-related Macular Degeneration | Choroidal NeovascularizationKorea, Republic of, Croatia, Germany, India, Russian Federation, Turkey, United Kingdom, Egypt, Israel, Belgium, Denmark, Hungary, Slovenia, Spain, Switzerland, Italy, Portugal, Slovakia, Chile
-
Quark PharmaceuticalsPfizerCompletedAge Related Macular DegenerationSpain, Korea, Republic of, Turkey, Taiwan, United States, Israel, Austria, Philippines, Denmark, Hong Kong, India
-
Novartis PharmaceuticalsCompletedPathological MyopiaGermany, India, Japan, Turkey, Austria, Switzerland, Italy, Lithuania, Hungary, France, Slovakia, United Kingdom, Korea, Republic of, Portugal, Hong Kong, Canada, Singapore, Spain, Latvia, Poland
-
Genexine, Inc.UnknownCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Seoul St. Mary's HospitalGenexine, Inc.UnknownCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Genexine, Inc.CompletedCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Genexine, Inc.UnknownCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Samsung Medical CenterMerck KGaA, Darmstadt, GermanyCompletedNeuroendocrine Carcinoma, Grade 3Korea, Republic of
-
BioLeaders CorporationUnknownCervical Intraepithelial Neoplasia Grade 2/3Korea, Republic of
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlActive, not recruitingType 3 Von Willebrand's DiseaseFinland, France, Germany, Hungary, Iran, Islamic Republic of, Italy, Netherlands, Spain, Sweden, United Kingdom
-
Seelos Therapeutics, Inc.TerminatedSpinocerebellar Ataxia Type 3United States, Spain, Korea, Republic of, Australia, United Kingdom, Brazil, Germany, Portugal